[对子宫内膜癌的最新化疗]
Kensuke Sakai1, Wataru Yamagami
1Dept. of Obstetrics and Gynecology, Keio University School of Medicine.
对子宫内膜癌的较新的治疗方法,包括免疫检查点抑制剂 (ICI) 和抗体-药物联合体 (ADC),正在改善患者的治疗结果. 这些进展为晚期或复发的子宫内膜癌提供了新的希望.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 传统的化疗 (例如,阿德里亚米辛+西斯普拉丁,帕克利塔塞尔+卡博普拉丁) 是子宫内膜癌的标准.
- 治疗领域正在不断发展,出现了新的治疗策略.
研究的目的:
- 审查最近对子宫内膜癌药物治疗的进展.
- 突出免疫检查点抑制剂 (ICI) 和抗体药物联合体 (ADC) 的影响.
主要方法:
- 最近的第三期临床试验的审查 (例如,NRG-GY018,DUO-E).
- 对日本近期针对晚期或复发性子宫内膜癌的监管批准进行分析.
- 对抗体-药物合物 (ADCs) 持续发展的概述.
主要成果:
- 将ICI添加到paclitaxel+carboplatin化疗中可以显著改善子宫内膜癌的预后.
- 现在,日本已批准使用布罗利祖马布或杜尔瓦卢马布的联合疗法来治疗晚期/复发性疾病.
- 针对HER2,TROP2和其他抗原的抗体-药物联合体 (ADCs) 显示出作为未来治疗方法的希望.
结论:
- 免疫检查点抑制剂 (ICI) 代表了子宫内膜癌治疗的重大进展.
- 抗体-药物结合物 (ADC) 正在成为对子宫内膜癌的有前途的新疗法选择.
- 不断变化的治疗环境为患有晚期或复发性子宫内膜癌的患者提供了更好的选择.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
